PI3Kα-IN-19 | MedChemExpress (MCE)
PI3Kα-IN-19 (Compound 1) is a PI3Kα inhibitor with a targeted binding site at the p110α catalytic subunit. PI3Kα is one of the most common dysregulated kinases used in cancer research[1].
| Trivial name | PI3Kα-IN-19 |
| Catalog Number | HY-163360 |
| Research Area | Cancer |
| CAS# | 885692-56-8 |
| Purity | ≥98.0% |
| SMILES | O=C(C1=NC(C#N)=CN1)NC2=CC=C(C(CC3)CCN3C(C4=C[N+]([O-])=CC=C4)=O)C=C2C5=CCCCC5 |
| Size | 1 mg |
| Supplier Page | https://www.medchemexpress.com/pi3kα-in-19.html |